Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Detailed Quotes

CNTB Connect Biopharma

Watchlist
0.743
+0.008+1.09%
Close 11/25 13:00 ET
0.7430.0000.00%
Post Mkt Price 11/25 13:02 ET
High
0.750
Open
0.701
Turnover
1.52K
Low
0.701
Pre Close
0.735
Volume
2.07K
Market Cap
40.86M
P/E(TTM)
Loss
52wk High
5.990
Shares
55.02M
P/E(Static)
Loss
52wk Low
0.557
Float Cap
13.82M
Bid/Ask %
60.00%
Historical High
29.274
Shs Float
18.61M
Volume Ratio
0.17
Historical Low
0.557
Dividend TTM
--
Div Yield TTM
--
P/B
0.19
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
6.70%
Avg Price
0.733
Lot Size
1
Float Cap
13.82M
Bid/Ask %
60.00%
Historical High
29.274
Shs Float
18.61M
Volume Ratio
0.17
Historical Low
0.557
Dividend TTM
--
P/B
0.19
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
6.70%
Avg Price
0.733
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist